Michael S. Aberman, VP Strategy and Investor Relat at REGENERON PHARMACEUTICALS INC (REGN), sold 8,750 shares at $350.00 ($3.1M) on 2014-08-19, disclosed to the SEC on 2014-08-19.
Scheduled sale ($3.1M) by VP Strategy and Investor Relat under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $351.06 | 1,296 | $455K | 14.8% |
| 2 | $351.06 | 3,843 | $1.3M | 44.0% |
| 3 | $350.00 | 3,611 | $1.3M | 41.2% |
| Total | $350.62 avg | 8,750 | $3.1M | 100% |
| Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |